Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Rapid depression treatment in cancer patients


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12610001011077

Organisation Name: University of Otago

Overal Status: Recruiting

Start Date: 23/03/2011

Brief Summary: Low dose ketamine has been shown to produce rapid (within hours) improvements in mood in patients with major depression. We plan to test ketamine in depressed patients with advanced cancer, for whom rapid improvement in mood may be particularly important in the context of limited life expectancy. The study has 3 stages: Stage 1: showing that ketamine improves mood; Stage 2: showing this effect can be maintained after repeated (weekly) dosing); and Stage 3: exploring the relationship between dose and improvement in mood.

Countries:
  • New Zealand
Conditions:
  • Major depressive disorder
  • Cancer


Total execution time in seconds: 0.082587003707886